NCT02880930View on ClinicalTrials.gov

Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

February 28, 2019

Conditions
Asthmatic CrisisWheezing
Interventions
DIETARY_SUPPLEMENT

Fultium-D3 drops (Internis)

Oral daily doses of vitamin D3 (400 IU for 3 months; and 1,000 IU for an additional 3 months)

Trial Locations (1)

E1 1BB

The Royal London Hospital, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT02880930 - Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT) | Biotech Hunter | Biotech Hunter